Healthcare & Life Sciences
Clarametyx Biosciences
United States
series-a
series-a
Stage
1
Investors
About
Clarametyx Biosciences is developing therapies and vaccines to treat and prevent pneumonia.
Explore Clarametyx Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.